EUVIMEDEUVIMED entdecken
Open Access

Combinatorial use of VHL and KEAP1 PROTACs reveals unexpected synergy and hook effect relief

Sehbanul Islam iD, Haihong Jin, Dong Liu, Dan Lu, Yunkai Zhang, Eric Christenson, Renxu Chang, Joel Austin, Anneliese Faustino, Thomas Beer, Hsin-Yao Tang, Lan Huang und 2 weitere

Genes & Development · 2026

DOI: 10.1101/gad.352916.125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Development, 2026. Verfasst von Sehbanul Islam und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Proteolysis, Von Hippel-Lindau Tumor Suppressor Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Seed Therapeutics, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules bridging a protein with an E3 ubiquitin ligase, promoting its ubiquitylation and degradation. However, PROTACs are not without limitations, including suboptimal target degradation and the “hook effect,” a phenomenon where high PROTAC concentrations reduce efficacy due to inactive binary complex formation. In this study, we introduce a novel dual-PROTAC strategy utilizing two distinct E3 ligases, such as KEAP1 and VHL, to synergistically degrade KRAS(G12D) and androgen receptor (AR) by promoting ubiquitin chain elongation and also mitigating the hook effect. In conclusion, a dual-E3 ligase approach represents a promising avenue for optimizing PROTAC-based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kelch-Like ECH-Associated Protein 1ProteolysisVon Hippel-Lindau Tumor Suppressor ProteinHumansUbiquitinationUbiquitin-Protein LigasesReceptors, AndrogenProto-Oncogene Proteins p21(ras)Cell Line, TumorProteolysis Targeting Chimera

Stichwörter der Autor:innen

KRASPROTACdegradation

Substanzen

Kelch-Like ECH-Associated Protein 1Von Hippel-Lindau Tumor Suppressor ProteinKEAP1 protein, humanUbiquitin-Protein LigasesReceptors, AndrogenVHL protein, humanProto-Oncogene Proteins p21(ras)Proteolysis Targeting Chimera

Autor:innen und Institutionen

  • Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • SEED Therapeutics, Inc., King of Prussia, Pennsylvania 19406, USA.
  • Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
  • Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; businol@upenn.edu.

ORCID-Profile: Sehbanul Islam, Luca Busino

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • Seed Therapeutics, Inc.
  • American Cancer Society
  • National Cancer Institute
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Islam, S., Jin, H., Liu, D., Lu, D., Zhang, Y., Christenson, E., Chang, R., Austin, J., Faustino, A., Beer, T., Tang, H. Y., Huang, L., Tonra, J. R., & Busino, L. (2026). Combinatorial use of VHL and KEAP1 PROTACs reveals unexpected synergy and hook effect relief. Genes & Development. https://doi.org/10.1101/gad.352916.125

Vancouver

Islam S, Jin H, Liu D, Lu D, Zhang Y, Christenson E, et al. Combinatorial use of VHL and KEAP1 PROTACs reveals unexpected synergy and hook effect relief. Genes & Development. 2026. doi:10.1101/gad.352916.125

BibTeX
@article{Islam2026,
  author = {Islam, Sehbanul and Jin, Haihong and Liu, Dong and Lu, Dan and Zhang, Yunkai and Christenson, Eric and Chang, Renxu and Austin, Joel and Faustino, Anneliese and Beer, Thomas and Tang, Hsin-Yao and Huang, Lan and Tonra, James R and Busino, Luca},
  title = {Combinatorial use of VHL and KEAP1 PROTACs reveals unexpected synergy and hook effect relief},
  journal = {Genes & Development},
  year = {2026},
  doi = {10.1101/gad.352916.125}
}
Kostenlos starten →